Evaluation of left ventricle diastolic dysfunction in ischemic heart disease by CMR: Correlation with echocardiography and myocardial scarring  by Hosam El Din Behairy, Noha et al.
The Egyptian Journal of Radiology and Nuclear Medicine (2014) 45, 1099–1104Egyptian Society of Radiology and Nuclear Medicine
The Egyptian Journal of Radiology andNuclearMedicine
www.elsevier.com/locate/ejrnm
www.sciencedirect.comORIGINAL ARTICLEEvaluation of left ventricle diastolic dysfunction
in ischemic heart disease by CMR: Correlation
with echocardiography and myocardial scarring* Corresponding author.
E-mail address: nohabehairy@gmail.com (N. Hosam El Din Behairy).
Peer review under responsibility of Egyptian Society of Radiology and
Nuclear Medicine.
http://dx.doi.org/10.1016/j.ejrnm.2014.07.007
0378-603X  2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.Noha Hosam El Din Behairy a,*, Mohamed Homos a, Ahmed Ramadan a,
Sherif Osama El Sayed Gouda ba Radiology Department, Kasr El Aini Hospital, Cairo University, Egypt
b Cardiology Department, Kasr El Aini Hospital, Cairo University, EgyptReceived 6 July 2014; accepted 27 July 2014
Available online 16 August 2014KEYWORDS
Cardiac magnetic resonance;




Diastolic heart failureAbstract Objective: To detect the value of cardiac MR imaging in assessment of left ventricle dia-
stolic function in patients with ischemic heart disease compared to echocardiography and to corre-
late the degree of dysfunction to the extent of myocardial scarring.
Patients and methods: We examined 40 patients with known coronary artery disease. Mean
patient’s age was 48 ± 10. All patients were subjected to 2D echocardiography and CMR including
transmitral ﬂow and left atrial planimetry. The degree of diastolic dysfunction was detected and
correlated with the echocardiographic results and the extent of myocardial scarring.
Results: On CMR, 35% of the cases had grade I diastolic dysfunction, 35% showed grade II, 15%
had grade III while 15% showed normal diastolic function. CMR showed 94.12% sensitivity, 100%
speciﬁcity and 95% accuracy. Excellent agreement with echocardiography was detected (Kappa
coefﬁcient 0.931). There was a signiﬁcant correlation between the degree of diastolic dysfunction
and the extent of myocardial scarring with Spearman’s correlation coefﬁcient of 0.492 and
p= 0.028.
Conclusion: CMR has comparative results to echocardiography in assessment of diastolic dysfunc-
tion. We found a signiﬁcant correlation between the degree of diastolic dysfunction and the extent
of myocardial scarring.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.1. Introduction
The interest in diastolic dysfunction, which is present in vari-
ous heart diseases, has been growing for many years. Over
1100 N. Hosam El Din Behairy et al.the past 2 decades, the concept of heart failure with preserved
ejection fraction has emerged (1).
Ischemic heart disease is one of the main causes of diastolic
heart failure. The presence of diastolic dysfunction predicts a
poor prognosis in patients with coronary artery disease (2).
Heart failure with preserved ejection fraction has become a
diagnostic and therapeutic challenge, since its morbidity and
mortality are similar to those of heart failure with deteriorated
left ventricular ejection fraction (3). Echocardiography is the
method of choice for diastolic function testing in clinical prac-
tice. Cardiac MR imaging (CMR) is often limited to evalua-
tion of systolic function, including analysis of regional wall
motion, measurement of mass and volume and estimation of
ejection fraction. However, CMR offers a variety of applica-
tions for evaluation of diastolic function, moreover, it has
much more superiority to echocardiography in myocardial
assessment (4). The aim of this study is to evaluate the value
of cardiac MR imaging in assessment of left ventricular
diastolic function in ischemic heart disease (using transmitral
ﬂow and atrial size parameters) compared to echocardiogra-
phy and to correlate the degree of dysfunction to the extent
of myocardial scarring detected by delayed myocardial
enhancement.
2. Patient and methods
2.1. Study population
Forty patients with known ischemic heart disease were
enrolled in this study. Patient’s mean age was 48 ± 10 years,
30 were males. Patients were diagnosed clinically, laboratory,
ECG and by CT coronary angiography ± coronary catheteri-
zation. Exclusion criteria were the presence of atrial ﬁbrilla-
tion, mitral regurge or stenosis as well as other known
contraindications to CMR eg. claustrophobia and pace mak-
ers. All participants gave informed written consent. The study
was approved by the Institutional Ethics Committee.
2.2. Echocardiography acquisition and analysis
Standard echocardiographic and Doppler recordings were per-
formed by an experienced sonographer. Echocardiography
was done using a Philips IE-33 machine equipped with
2.5 MHz transducer. Mitral diastolic inﬂow was interrogated
using pulsed-wave Doppler from the apical 4-chamber view
with the sample volume placed at the level of the mitral leaﬂet
tips. Mitral early diastolic peak (E wave), late peak (A wave)
velocities, E/A ratio, and deceleration time (DT) were mea-
sured. Planimetry for left atrial size was also performed.
3. CMR acquisition and analysis
All patients were imaged by a 1.5 T super conducting magnet
(Gyroscan Achieva, Philips Medical Systems, Best, The Neth-
erlands) using 5 channel phased-array cardiac coil.
The CMR protocol included cine imaging of the left ventri-
cle using an ECG-gated, breath-hold balanced turbo ﬁeld echo
sequence (b-TFE) in two, four chamber and short axis views
with the following parameters: repetition time (TR)/echo time
(TE), 4.4/2.5; 25 cardiac phases; matrix 128 · 128; FOV 300,NSA 1, ﬂip angle 15; slice thickness 8 mm and scan time of
7–12 s.
Transmitral ﬂow was assessed via through-plane phase con-
trast images positioned at the top of the opened mitral valve
perpendicular to the left ventricular inﬂow tract with the fol-
lowing parameters: repetition time (TR)/echo time (TE),
7/3.2; matrix 256 · 192; FOV 38, ﬂip angle 20; slice thickness
8 mm. A region of interest (ROI) was placed at the center of
the mitral valve oriﬁce in the phase contrast images and then
propagated to the other phases to obtain the transmitral ﬂow
(TMF) curve, early diastolic peak/late peak velocities ratio
(E/A ratio) and deceleration time (DT).
For delayed contrast enhancement imaging, intravenous
gadolinium-DTPA was given (0.2 mmol/kg) followed 10–
15 min later by breath-hold segmented inversion recovery bal-
anced turbo ﬁeld echo (IR-b-TFE) in 4chambers, 2chambers
and short axis images, optimizing the inversion time for ade-
quate myocardial suppression and scar visualization by using
the Look Locker sequence. The following parameters were
used: TR/TE, 3.8/1.86; inversion time (TI), 260–350; FOV
300; matrix 128 · 128; ﬂip angle 15; slice thickness, 8 mm
and scan time of 9–15 s.
All images were interpreted by two experienced radiologists
who were blinded to patient0s echocardiographic data.3.1. Analysis of LV function
The 17-segment model according to the AHA (American
Heart Association) deﬁnition for the left ventricle was used
to analyze left ventricular function and delayed enhancement
per segment.
LV global function was calculated by the Philips extended
work station (EWS) View Forum 2.6, after the manual tracing
of the endocardial and epicardial contours of the left ventricu-
lar wall at end diastole and end systole on the short axis cine
images. Images were analyzed for wall thickness and wall
motion abnormality and EDV, ESV, CO, SV, EF and CI were
calculated.3.2. Analysis of LV diastolic dysfuntion
Diastolic function was considered normal if E/A was 1–1.5
and DT> 200 ms; grade I dysfunction if E/A decreased
below 1; grade II dysfunction if E/A 1–1.5 with DT 160–
200 ms; grade III dysfunction if E/A above 2 and DT
<160 ms. (Fig. 1).
Left atrial size was assessed at end systole by manual
endocardial delineation (planimetry) in the four chamber or
two chamber views (Fig. 2). LA was considered dilated if
planimetry showed an area >24 cm2.3.3. Analysis of delayed enhancement
Segmental enhancement was quantiﬁed by the Philips (EWS)
View Forum 2.6 in all 17 segments. The presence of enhance-
ment in each segment was scored by visually assessing the area
showing late gadolinium enhancement as compared with LV
myocardium in each segment. The presence, distribution,
extent and pattern of enhancement were detected.
Fig. 1 Through-plane one-directional velocity-encoded MRI results in a time–ﬂow rate graph, which revealed reversed E/A ratio
denoting grade I diastolic dysfunction (a), pseudo-normal E/A ratio with decreased DT below 200 ms denoting grade II diastolic
dysfunction (b) E/A ratio more than two denoting grade III diastolic dysfunction (c).
Fig. 2 Delayed myocardial enhancement image shows transmural and subendocardial enhancement at the apex of the heart (a)
planimetry of the left atrium by manual tracing of the atrial wall denoting dilated left atrium of 26 cm3.
Table 1 Showing grades of diastolic dysfunction and dilated
LA by both echocardiography and CMR.
Echocardiography CMR
Grade I diastolic dysfunction 14 (35%) 14 (35%)
Grade II diastolic dysfunction 12 (30%) 14 (35%)
Grade III diastolic dysfunction 8 (20%) 6 (15%)
Normal diastolic function 6 (15%) 6 (15%)
Dilated LA 24 (60%) 30 (75%)
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Continuous variables were described as mean ± SD. Categor-
ical data were presented with absolute frequencies and percent-
ages. Comparison between study diagnostic tools was done
using McNemar test. Agreement was tested using kappa statis-
tic. Correlation between categorial variables was done using
Spearman rank correlation. Accuracy was presented in terms
of sensitivity, speciﬁcity, +ve predictive value, ve predictive
value and overall accuracy. p values <0.05 was considered sta-
tistically signiﬁcant. All statistical analyses were done using
SPSS version 15.0 software for Windows (SPSSInc. Chicago,
IL).
4. Results
All cardiac examination was diagnostically satisfactory by
both CMR and echocardiography. Overall patients had mean
end diastolic value of 176 ml, end systolic value of 101 ml,
stroke value of 75 ml and mean ejection fraction was 43%.
We had 26 patients with systolic and diastolic heart failure.
Eight patients had isolated diastolic heart failure while nonehad isolated systolic heart failure. Six patients did not have
heart failure.4.1. Transmitral ﬂow and left atrial size
Transmitral ﬂow by echocardiography showed that 14/40
patients (35%) had grade I diastolic dysfunction, 12/40
(30%) showed grade II diastolic dysfunction, 8/40 (20%) had
grade III diastolic dysfunction, while 6/40 patients (15%)
showed normal diastolic function. (Table 1) (Fig. 3)
Fig. 3 At end-systole, an acquisition plane is positioned at the mitral valve (a). Through-plane one-directional velocity-encoded MRI
magnitude image (b) and velocity image (c) time–ﬂow rate graph (d) of the same patient in Fig. 2 shows grade III diastolic dysfunction.
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ease (35%) had grade I diastolic dysfunction, 14/40 (35%)
showed grade II diastolic dysfunction, 6/40 (15%) had grade
III diastolic dysfunction while 6/40 patients (15%) showed
normal diastolic function. (Table 1)
There was no statistically signiﬁcant difference (p= 0.000)
between CMR and echocardiography in assessing grades of
diastolic dysfunction. CMR showed 94.12% sensitivity,
100% speciﬁcity and 95% accuracy. Excellent agreement with
echocardiography was detected (Kappa coefﬁcient 0.931).
Thirty patients (75%) showed dilated left atrium by CMR
while 24 patients (60%) had dilated left atrium by echocardi-
ography. Echocardiography showed 80% sensitivity, 100%
speciﬁcity and 85% accuracy. MRI showed 94.12% sensitivity,
100% speciﬁcity, and 95% accuracy with a good Kappa agree-
ment of 0.667 and p= 0.002.
4.2. Scarred myocardial segments
We had 142 total scarred myocardial segments in our study
with a minimum of zero, maximum of 22 segments (mean 3.55
SD 3.517). All patients (with +ve delayed enhancement)
showed subendocardial enhancement within the territory ofTable 2 Correlation between the degree of diastolic dysfunction an
Grades of diastolic dysfunction No of scarr
Grade I diastolic dysfunction 38 segment
Grade II diastolic dysfunction 70 segment
Grade III diastolic dysfunction 32 segment
Normal diastolic function 0 segments
Spearman0s correlation coefﬁcient 0.492 and p= 0.028.one or more coronary arteries, 18 patients showed transmural
enhancement pattern.
LGE (late gadolinium enhancement) as indicator of myo-
cardial scarring was seen in 38 myocardial segments in patients
with grade I diastolic dysfunction (n= 14), 70 segments in
grade II diastolic dysfunction patients (n= 14), 32 segments
in grade III dysfunction patients (n= 6) and no LGE in
patients with normal diastolic function (n= 6). There was a
signiﬁcant correlation between the degree of diastolic dysfunc-
tion and the extent of myocardial scarring with Spearman’s
correlation coefﬁcient 0.492 and p= 0.028. (Table 2).
5. Discussion
Heart failure with preserved ejection fraction represents
approximately 40–50% of all cases of heart failure, and its
prevalence is increasing (1). Diastolic dysfunction and coro-
nary artery disease are interrelated. The complications of cor-
onary artery disease, myocardial ischemia or infarction, are
major causes of diastolic dysfunction. Diastolic dysfunction
refers to abnormal mechanical diastolic properties of the left
ventricle (relaxation and ﬁlling dynamics). Left ventricular
ejection fraction may be normal or decreased (5,6).d the extent of myocardial scarring.





Evaluation of left ventricle diastolic dysfunction in ischemic heart disease 1103In this study we had eight cases (20%) of heart failure with
preserved left ventricle ejection fraction (EF 57–64%) and
abnormal diastolic function (grade I–III) while 26 cases
(65%) showed decreased left ventricle ejection fraction (EF
32–51%) with abnormal diastolic function. Six cases (15%)
did not have heart failure.
Echocardiography is the method of choice for diastolic
function testing in clinical practice with the mitral ﬂow pattern
and left atrial size having predictive value of future heart fail-
ure hospitalization and mortality (7,8). However, TTE has
important disadvantages, including limited ﬁeld of view,
dependence on sample volume location, cosine h errors relative
to the ﬂow direction and an inability to image approximately
15–20% of patients (9).
Transmitral ﬂow is an instantaneous marker of the LV ﬁll-
ing pressure gradient between the LA and LV (1). In our study,
assessment of E/A ratio for diastolic function testing was done
by phase contrast MR technique across the mitral valve in
addition to echocardiography. This showed excellent agree-
ment between CMR and echocardiography regarding the pat-
terns of diastolic dysfunction (p< 0.0001) in agreement with
previous studies (9,10).
LA size is a chronic marker of diastolic dysfunction and
cardiovascular risk (1). Our study showed that echocardiogra-
phy underestimated the left atrial size compared to CMR with
overall sensitivity of 80%, speciﬁcity of 100% and accuracy of
85% (p= 0.002) which was in line with a study carried out by
Tobias et al. (11) that showed that echocardiography underes-
timates LA size with up to 32% compared with CMR and
MSCT (p< 0.001).
Late gadolinium enhancement (LGE) using cardiac mag-
netic resonance (CMR) has emerged as the gold-standard tech-
nique for imaging of myocardial scar. With appropriate
settings, normal myocardium appears nulled or black, whereas
nonviable regions appear bright or enhanced (12).
LGE-CMR is a well-established technique to non-inva-
sively detect foci of collagen deposition in vivo. Importantly,
it has been documented that LGE results show a good corre-
lation with direct histological ﬁndings (13,14).
In our study, the most benign alteration in diastolic func-
tion, termed impaired relaxation (grade I) and characterized
by prolonged deceleration time of early diastolic ﬁlling and
decreased E/A, is associated with delayed relaxation in the
presence of normal LV ﬁlling pressures. At the other end of
the spectrum, a restrictive ﬁlling pattern (grade III) is charac-
terized by shortened deceleration time, increased E/A, and
shortened relaxation time, and reﬂects high LV ﬁlling pres-
sures. The pseudonormal ﬁlling pattern (grade II) is considered
a condition of intermediate severity. Our data showed a signif-
icant correlation between the extent of myocardial scarring; as
number of scarred segments by LGE-CMR according to the
17-segment model of the left ventricle proposed by the Amer-
ican Heart Association (AHA) and the degree of left ventricu-
lar diastolic dysfunction with a correlation coefﬁcient of 0.492
and (p= 0.028).
This could be explained by the effect of increased tissue col-
lagen deposition on altering the viscoelasticity of the myocar-
dium impairing relaxation, diastolic recoil and passive stiffness
(15,16). In addition, it has been documented that the size and
distribution of a myocardial infarction from late gadolinium
enhancement are of signiﬁcant prognostic value for post-
infarction patients (17) and that there is a direct relationshipbetween the amount of remote myocardial scarring determined
with nonstress DE-MRI and baseline resting systolic func-
tional impairment in chronic ischemic heart disease (18).
Diastolic dysfunction and LGE myocardial scarring were
previously studied in a broad range of cardiac conditions as
well as patients without structural heart disease. Those studies
showed that subjects with normal diastolic function exhibited
no or minimal ﬁbrosis. In contrast, the majority of patients
with cardiomyopathy (regardless of etiology) had abnormal
diastolic functional indices and substantial ﬁbrosis with LGE
remained signiﬁcantly correlated with degree of diastolic dys-
function (p= 0.0001) (19–21).
Although, Heymon et al. (22) stated that the extent of myo-
cardial scarring was weakly or not signiﬁcantly correlated with
LV myocardial and chamber diastolic functional indices. This
contradiction with our results could be explained by the differ-
ence in study groups as Heymon studied patients with early
reperfused acute myocardial ischemia in whom non-infarcted
myocardial circumferential strain had high inﬂuence on LV
diastolic functional indices while myocardial scarring has more
contribution to LV diastolic dysfunction in chronic ischemia.
CMR has comparative results to echo in assessment of dia-
stolic dysfunction, in addition, CMR has a very low intraob-
server and interobserver variability, not limited by the body
habitus. CMR allows comprehensive left ventricular assess-
ment particularly detection of myocardial scarring that showed
a signiﬁcant correlation with the degree of diastolic dysfunc-
tion in ischemic heart disease.
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